Tia Bush's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 125,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Feb. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 125,000 | 125,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Sale of securities on an exchange or to another person at price $ 16.86 per share. | 01 Feb 2025 | 11,000 | 121,503 | - | 16.9 | 185,406 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. | 01 Feb 2025 | 8,693 | 132,503 | - | 16.9 | 147,086 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.35 per share. | 31 Dec 2024 | 6,419 | 141,196 | - | 16.4 | 104,951 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 16 Dec 2024 | 17,813 | 165,428 | - | 3.8 | 68,580 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 17,813 | 27,187 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 16 Dec 2024 | 17,813 | 147,615 | - | 18 | 320,634 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Sale of securities on an exchange or to another person at price $ 16.36 per share. | 16 Dec 2024 | 9,611 | 147,615 | - | 16.4 | 157,256 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.79 per share. | 30 Sep 2024 | 6,419 | 157,226 | - | 15.8 | 101,356 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 30 Jun 2024 | 6,419 | 163,645 | - | 9.0 | 57,964 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Technology & Quality Ofc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.30 per share. | 31 Mar 2024 | 6,419 | 170,064 | - | 11.3 | 72,535 | Ordinary Shares |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 170,000 | 170,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 42,500 | 180,345 | - | 0 | Ordinary Shares | |
| Centessa Pharmaceuticals plc | Tia Bush | Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 01 Feb 2024 | 3,862 | 176,483 | - | 8.2 | 31,630 | Ordinary Shares |